登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Crizotinib versus conventional chemotherapy in advanced ALK-positive lung cancer
Crizotinib versus conventional chemotherapy in advanced ALK-positive lung cancer
收藏
DataCite Commons
2020-08-03 更新
2026-05-07 收录
ALK阳性肺癌
靶向药物疗效
数据链接：
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014010423
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Systematic review protocol registration
应用场景：
提供机构：
Centre for Reviews and Dissemination - CRD
创建时间：
2015-08-07
相关数据集
Levonorgestrel-releasing intrauterine system use in women with symptomatic leiomyoma: a systematic review
Systematic review protocol registration
DataCite Commons
2020-08-03 更新
6
0
Dataset from Phase 3, Randomized, Open-label Study Of The Efficacy And Safety Of Crizotinib Versus Pemetrexed/Cisplatin Or Pemetrexed/Carboplatin In Previously Untreated Patients With Non-squamous Carcinoma Of The Lung Harboring A Translocation Or Inversion Event Involving The Anaplastic Lymphoma Kinase (Alk) Gene Locus.
ALK阳性肺癌
靶向治疗疗效评估
This study will evaluate the anti-cancer effects of crizotinib when compared with standard chemotherapy in patients with ALK positive lung cancer.
NIAID Data Ecosystem
3
0
The effectiveness of Atraumatic Restorative Treatment (ART) compared to conventional treatment in restoring class I dental cavities in permanent molar and premolar teeth: a systematic review
牙科临床治疗比较
系统评价证据合成
Systematic review protocol registration
DataCite Commons
2020-08-03 更新
2
0
Comparison of laparoscopy with laparotomy for cervical cancer in long-term outcomes: systematic review
妇科肿瘤手术
临床系统评价
Systematic review protocol registration
DataCite Commons
2020-08-03 更新
3
0
Immunotherapy in cervical cancers, a systematic review of published and on-going Phase II and III trials and critical appraisal
肿瘤免疫治疗
临床试验系统综述
Systematic review protocol registration
DataCite Commons
2020-08-03 更新
2
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
